Chairman

President

Executive Director

MichioOishi

Osamu
Nagayama

YoshiakiTsukamoto

Professor Emeritus,
University of Tokyo

President
Chugai PharmaceuticalCo., Ltd.

Ex-Professor, Titech.
Ex-Director-Generalof Shikoku Bureau of METI

In solving global problems, such as an increasing population, food shortages,
environmental pollution, and running out of oil, biotechnology has been aneﬀective means of addressing the issues and is arousing great expectations
for the future.
For example, in the ﬁeld of pharmaceutical products, interferon as therapeutic
agents for hepatitis C, erythropoietin as a therapeutic agent for nephrogenic
anemia, and actemra, which is the ﬁrst antibody drug in Japan for rheumatoid
arthritis, have been launched in the market as epoch-making pharmaceuticalproducts that bring blessings to many patients.
In the ﬁeld of the environment and energy, enzymes for compact detergent
have been used by many households and plastics made from biomass havebeen more widely used as parts for automobiles.
In the ﬁeld of agriculture and food, transgenic crops have been contributing
to a steady supply of food and transgenic blue roses are now on the market.
The size of the domestic market for bioindustry, i.e. the industry to whichsuch biotechnology has been applied, is said to have exceeded 2 trillion yen.
In the years ahead, bioindustry will contribute to innovations in every aspect

JBA Activity Report 2011of society, lead the Japanese economy as a knowledge-intensive growing

contents

industry, and play an important role in achieving safe and aﬄuent lives.

Mission3

1 Policy Proposal and Dialogues 4

About JBA
JBAʼs roots date back to Shusei Kyokai（the Distilled Spirits Institute）
established in 1942.
Its name, after being changed to the Japanese Association of Industrial
Fermentation, was renamed to Japan Bioindustry Association: JBA in 1987.
Members : Corporate members ー193 companies（pharmaceutical, food, chemical
cosmetic and machinery companies）
Public members ー 95 organizations
Individual members ー 818（universities and corporate researchers）
Budget : 610 million yen（2011）

2

2 Science Agora of the Information
on Advanced Biotechnology
53Open Innovationby the Network

6

4

International Network

11

5

Establish the Infrastructureof Bioindustry

13

Activity Report 2011

MissionJBA contributes to bioindustry and related industries
in the ﬁelds of health, environment and food.
To solve the common problems of humans, it is necessary to implement
measures that rapidly apply the outstanding results of Japanʼsfundamental bioscience researches. Therefore, for the purpose ofpromoting the use of such results, one of the important tasks is making
policy recommendations for the science-based review of regulations andthe promotion of the strategy through collaboration among industry,
academia, and the government.
Furthermore, a system of collaboration is also important with regard tobioindustry organizations in diﬀerent countries of the world in order tosolve global problems related to climate change and biodiversity.
Scientiﬁc development should be accelerated and open innovations are
essential for industrialization. JBA holds BioJapan in order to nurture bioventure companies and promote the formation of bio-clusters.
In addition to these activities, JBA contributes to peopleʼs lives by
establishing the infrastructure for the growth of the bioindustry.

1

Policy Proposal
and Dialogues

42

Science Agoraof the Information
on Advanced Biotechnology

International Network
Formation

5

3Open Innovationby the Network

Establish
the Infrastructureof Bioindustry

5 actions of3

1
actionPolicy Proposal and Dialogues
JBA has oﬀered a variety of policy proposals and dialogs for the sound developmentof biotechnology and bioindustry in cooperation
with member companies, universities and government bodies.

JBA cooperates in the activities of the Japan Association of Bioindustry
Executives* as an organization for integrating opinions and to makeeffective proposals for national policies. In addition, JBA endeavors
to integrate opinions from the standpoint of science by transmitting
public comments, planning and sponsoring the Life Science Summit,
and planning seminars in Bio Japan.

Member companies
Academic conference

Integrationof opinions

Business environment
Research environment
Maintenance/improvement

JBA & JABEX
Transmitting
publiccomments

Reﬂectionin the policies

ProposalPresent Cabinet＊ Japan Association of Bioindustry Executives（JABEX）established in June 1999.
The current number of members is 56. It is an extensive congregation of representatives ofJapanese bioindustry-related organizations and is addressing the problems of thebioindustry, making proposals and taking action for the sound development of bioindustry.

Accomplishment
Policy Proposal“Growth Strategy for Bio-technology”（August 30, 2010）（Ⅰ）“New comprehensive science and technology strategy”

to survive the global competition- Formulation of “New comprehensive science and technology
strategy” to promote open innovation- Established the infrastructure for the realization of open
innovation- Education/human resource development and promotion ofscience communication to support the growth of biotechnology（Ⅱ）Growth strategy based on the strengths of biotechnology（speedy creation of new industries）- Live（Life）
Promotion of growth of health / medical care industries by
establishing the infrastructure to accelerate the creation ofLife Innovation.
- Lead a life（Green）
Technological development for resource-poor countries,
innovative technological development to lead the world andcreation of new industries in order to achieve a resources andcarbon recycling-oriented society- Eat（Green & Life）
Contribution to the food production in Japan and in the world
through the utilization of the results of genome research etc.,4and revitalization of the economy of local society throughestablishing brands of special local products.
Technological development and growth promotion of such
health/functional foods that serve to promote health andreduce disease risks.

Dialogues
Met with Prime Minister Hatoyama in December 2009.
“Growth strategy for biotechnology”/“New science andtechnology strategy”

Met with Mr. Kawabata, Minister of Education, Culture,
Sports, Science and Technology, Minister of State for Scienceand Technology Policy in February 2010.
Met with Mr. Naoshima, Minister of Economy, Trade andIndustry in April 2010.

2

Activity Report 2011

actionScience Agora of the Information
on Advanced Biotechnology
JBA is addressing the provision of biotechnology and new technical informationof the industry, discovery of seeds and industrialization in cooperation
with member companies, universities and government bodies.

JBA collects advanced biotechnology information in Japan and overseas,
conducts research on the latest development trends and discovers technicalseeds that may lead to new industries. JBA has those results shared incommon among the members through lectures and seminars. Furthermore,
JBA takes into consideration the project concept that should be deployedin cooperation with industry, government and academia.

Accomplishment
Sponsored lectures, seminars and study meetings : 46 times in total
during FY 2010.

Presenter

AcademyPublic agency
Company

The total number of subjects of lectures was 189, the contents of which consist ofpharmaceuticals, environment, and food + basic R&D, and the activities were very
active with the number of participants being 3408.
Subjects of lectures were selected on the condition that they
Subject : 189
Medicals & Careshould be opportune, take into consideration the proposal ofEnvironment & Production
each member, and eﬀorts were made to have the task recognition
Technical platform
shared in common among the members by requesting lectures
Food & Supplement
not only from academia but also from industry.

Symposiumon new resource bioconversion■ “Bioindustry in 2020”
Lecture & Panel discussion（June 17, 2010）

55.0%
24.3%
20.6%

42.3%
34.9%
16.9%
5.8%

Open Seminar “e-Bio”（August 24, 2010）（Electron-oriented Biotechnology）“Development of electron-oriented biotechnology（e-Bio）”
Masaharu Ishii, Associate Professor, University of Tokyo

Research Meeting on biologicals

Study meeting on biotechnology
toward the future■ No. 21（January 8, 2010）in Osaka
How far has nucleic acid drug DDS come?
■ No. 22（February 16, 2010）
Struggle against pollinosis■ No. 24（April 20, 2010）
Energy-saving biological carbon ﬁxation‒Green Innovation
for mitigation of greenhouse gas emissions and increase of
biomass production‒■ No. 25（May 10, 2010）
Future drug discovery through administration of noninvasive drug.

■ No. 19 (June 11, 2010)
Report on Overseas Trend : “Cell Culture Engineering XII/
Biomanufacturing & Single-use Systems Asia”“2nd Annual International Congress of Antibodies”
Lecture : “Search of human antibody speciﬁc aﬃnity peptide
and detection of antibody through phage library andapplication to puriﬁcation technology” “Creation of thiazole
derivative low-molecular ligand for antibody puriﬁcation”

Joint interactive meeting on biomass■ “‒Research on alcohol and biomass toward the postresource exhaustive civilization‒“（October 26, 2009）

Research Meeting on bioengineering RTD■ “Regenerative medicine / iPS cells（induced pluripotent
stem cell）（June 2, 2010）

5

3
actionOpen Innovation by the Network
In alliance with member companies, universities and the government, JBA provides opportunities
to help development of Biotechnology and industry

JBA holds an international comprehensive bio event = BioJapan*
as an effective means to build a business platform for promotionof alliances between parties, creation of opportunities foropen innovation, etc. Furthermore, through the activities ofinteractive meetings of nationwide bio groups, primarily aiming
for the development of drug-discovery bio-clusters/bio-venturecompanies, JBA not only promotes deepen exchanges withnationwide bio-cluster and bio groups but also aims to become thehub of those activities.

Venture member
Academia

Technology/seeds
Provision ofopportunities
supportJBA BioJapan
Interactive meetingon bio-clusters
Provision of the dataon ventures companies

Promotion of alliances
Open innovation
Promotion of business expansion

Member companies（Foreign companies）＊ BioJapan

International comprehensive bio event that contributes to the publicity
of biotechnology as a whole, starting in 1986 and having the longest history in Japan. It
has been held every year since 2004. It offers exhibitions, business partnering meetings,
technological presentations by universities / venture companies and theme seminars

Accomplishment

BioJapan2010 World Business Forum
Renaissance of Bioindustry
Bio Japan 2010 World Business Forum was held at
Paciﬁco Yokohama from Sep. 29 to Oct, 1.
【Subjects】1）Health, 2）Environment（ Green biotechnology）, 3）Food and 4）Cluster & Bio-ventures【Organizer & Special Support】Hosted by BioJapan
Organizing Committee : JBA, JHSF, STAFF, JBiC, JABEX,JPMA, KBDO and Nikkei BP inc.
Specially supported by City of Yokohama and cooperated
by Kanagawa Prefecture.
【Participants】The number of gross participants was
25,530 and exceeded the number in 2009 by 7% thanks

6

to more-developed Workshops.
【Exhibition】More than 400 companies and organizations
from all over the world presented their products andtechnologies at exhibition ﬂoor.
【Business partnering】Using the unique business-matchingsystem, participants in the event could get many
chance to meet their technological seeds to needs eachother. There were 2,000 meetings during the event.
【Academic workshop】This offers an opportunity forplanning of joint research with corporations through result
presentations by universities/public research institutions.

Activity Report 2011

Opening Ceremony

Exhibition

Welcome Address
Hiroshi Harada

Chairman JBA

Congratulatory Address

Congratulatory Address

Yoshikatsu Nakayama
Minister of Economy, Trade andIndustry

Masao Kurokawa
Vice Governor Kanagawa
Prefecture

Keynote Speech
Biomedical Innovation in the 21st Century
Sir William Castell
The wellcome Trust Board of Governors
ChairmanFuture medical care will be an evidencebased tailor-made medical care.
Molecular pathology and drug
designing will require teamwork andexperts on mathematics and physics
need to cooperate with molecularbiologists in terms of the identiﬁcationof algorithm. The government
should, among other things, play arole in environmental improvement .

Toward a New Generation of Renewable Fuels andChemicals
Todd Werpy
Archer Daniels Midland
Research and Development
Vice President Research（The person of the middle）

S&T and Innovation
Policy for Thriving in
the Future
Masuo Aizawa
Cabinet Oﬃce,
Government of Japan Executive member of the Council for Science andTechnology Policy （The person of the left）

Business partnering

Academic Seeds

Thirty-six organizations in total made impressive
presentations in the Forum. Throughout the three-day
period, the Forum was well attended and recorded a
total number of participants of approximately 1,750.

Academic seeds presentations were implemented ona larger scale than last year on the basis of outstanding
technical seeds provided by universities in orderto accelerate industry-academia joint research andtechnology transfer.

73Open Innovation by the Network

SeminarLife Innovation Summit

Food Summit“Japanʼs New Growth Strategy”（Health & Functional Food）“Can the life science industry contribute to Japanʼseconomic growth?”
The major pharmaceutical companies of the world arepromoting open innovation and developing and providing
new drugs based on the strategies. Japanʼs pharmaceuticalindustry also needs to meet expectations
as one of the driving industries of theJapanese economy.

“Science of and regulations on health food,and tasks for the development of industry”“Health food is considered important for the maintenanceof good health. Japan is a pioneer in the world in the ﬁeldof science and regulations with regard to health food.
Japan is expected to implement businessdeployment and play a leading role aspart of its global strategy in the future.”
Moderator
Toshio Shimizu

Moderator
Yasuchika Hasegawa

Professor, Faculty of Health and Human
Life, Nagoya Bunri University

President, Japan Pharmaceutical
Manufacturers Association

Speaker & Panelist
Takeshi Karasawa

Speaker & Panelist
Hiroshi Aimoto

Deputy Director-General of the Minsterʼs Secretariat, Ministry of
Health, Labour and Welfare

Director, Consumers Aﬀairs Agency, Food Labeling Division

Masahiko Nagao

Calpis Co., Ltd.
Microbiology & Fermentation Laboratory

Deputy Director-General of the Minsterʼs Secretariat, Ministry of
Economy, Trade and Industry

Yasunori Nakamura
Akira Kubo
Professor, Tokai University, School of Medicine

Beh Kian TeikSingapore Economic Development Board,
Biomedical Sciences, Director

Green Innovation Summit
Cluster & Venture Summit“Aiming for international cooperation”
Although an issue was raised by the moderator to the eﬀect
that the interaction among clusters is hard to continue,
there is a fact in the first place that Japanese bio-venturecompanies and bio-clusters are almost unknown in foreigncountries; therefore, the first step should be taken toincrease name recognition.

Although the time spent was limited, the lecture proved
to be a holoscopic one, covering the utilization situationof wooden biomass in foreign countries presented by
Sumitomo Chemical and Sumitomo Bakelite that are thecore players in the green bioindustry of Japan as well as by
Novozyme and Genencor, the two major manufacturers ofsaccharogenic amylase which is essential when utilizing
non-edible biomass.
Moderator
Hideaki Yukawa

Moderator
Hisaaki Sakata

Director, ResearchInstitute of Innovative
Technology
for the Earth

Specially-appointed
Professor, Cyber Media
Center,Osaka University

Speaker & Panelist
Skolling Otto
Karolinska Development AB Investment
Manager

Willem Dhooge
Flanders Bio Project Manager

William O. Bullock
North Carolina Biotechnology center Vice President

Jun Hosoya
Innovation Network Corporation of Japan Managing Director

8“Genencor andrenewable fuels
and chemicals”
Colin Michinson
Genencor Director
Biomass Applications

Speaker & Panelist
Hiroshi Hirose
President, Sumitomo Chemical Co., Ltd.

Yoshio Amano
Manager, Mitsubishi Corporation, New
Energy & Power Generation Division

Masahiro Samejima
Professor, University of Tokyo, Graduate
School of Agricultural and Life Sciences

Tomitaro Ogawa
Chairman, Sumitomo Bakelite Co., Ltd.

Activity Report 2011

Support for bio-venture companies and bio-clusters
Through the network with nationwide bio groups and clusters,
JBA actively promotes interaction among industry, academia,
and government to support and foster bio-venture companies
and form bio-clusters.
National Bio GroupInteraction Meeting

Hokkaido
Bio-industry
Association

Tohoku-area
Bio-industry
Promotion
Association

Okinawa
TLO

Yokohama
Foundation
for theAdvancement ofLife Sciences

National Bio-Clusters
Networking
Metropolitan
Bio Network（Base）

PharmaVally Center（Shizuoka）
NPO Kinki
Bio-industry
Development
Organization

ChugokuIndustrial
Innovation
CenterKurumeResearch
Park
ShikokuIndustry &Technology
Promotion
CenterStatistical data on
venture businessCorporate proﬁleof venture company
Support for overseas
expansion of
bio-venture businessAs part of the operations to form bioindustry
network that serves for local revitalization, JBA
has been convening the National Bio GroupInteraction Meeting. The network has been
formed with nationwide bio groups as a meansfor consultation of “All Japan,” and JBA has beenplaying a role in activity reports and informationexchange and a facilitator for bio-clusters ofblocks around Japan. JBA, whose activities arediversified, works out new bio-related projects
and enhances the relationships between theblocks. In addition, JBA has also been promotinginteractive activities with overseas bioorganizations in recent years and continuously
sponsoring the cluster summit as a means to
exchange opinions and promote interactions
with worldwide bio-clusters in BioJapan.

Accomplishment

The 7th Bio-Cluster Interaction Meeting（2011.2.3 〜 4）
（Cosponsor : JBA）

JBA held the National Bio Cluster Interactive Meeting
to promote industrialization of research results
and business seeds of each region that are taking a
progressive approach nationwide.
【Venue】Mie-Prefecture（Education and Cluster Hall）【Subject】“How to face the rapidly growing bioclusters in Asia? ““Expectations about the bio policiesof the new government”【Participants】Approximately 120 bio-cluster-relatedparties from throughout Japan

Support for overseas expansion of bio-venturebusiness and cooperation with JETROThe exchange of opinions and opportunities forinteraction with worldwide bio-clusters can be aneffective means to break through the bio-venturebusiness environment that tends to be occluded.
Therefore, by endeavoring to promote cooperation
with overseas major bio-clusters, JBA supported thematching between bio-venture companies and foreign
corporations. Furthermore, in order to multilaterally
and eﬀectively lead the activities to the results, JBA has
promoted further cooperation in terms of its activities
with JETRO. JBA has a close relationship with JETRO andsupported bio-venture companies by participating in
Bio-Europe Spring
Support imageetc. In addition, theabCorporate proﬁles
Support for
tie-up of the activity
Supportmatching
for preparing
in the JETRO BIOLINK
held concurrently
Participationin the domestic
with BioJapan is also
and overseas
exhibitions
an example, whereca complementarydSupport for
Publicity
relationship is being
exhibitions
established throughmutual activities.
e Follow-up

93Open Innovation by the Network

Metropolitan Bio Network activity
Management system of the Metropolitan Bio Network

Information service

JBA sponsored the activities under the cooperation withthe members in charge of business promotion consisting ofmember venture companies, pharmaceutical companies,
support organizations (National Institute of Advanced Industrial
Science, JETRO, Tokyo Small and Medium Business Investment& Consultation CO., LTD. Organization for Small & Medium
Enterprises and Regional Innovation, Japan., KPMG AZSA LLC
and Japan Pharmaceutical Manufacturers Association) and alsowith the members of the operating committee consisting of therepresentatives of member companies（15 to 18 persons）.
Information service JBA enhanced the contents and functions of thewebsite database of the members. JBA, also, provided the information
about the details of various events held by the Metropolitan Bio
Network, the information about public assistance measures or various
kinds of domestic bio-related information.

Bio business salon

Bio business salon Lectures and interactive meeting by special
speaker for participants from bio-venture companies, major
pharmaceutical companies, servicing companies, etc.
Research Meeting and Seminar

JBA, inviting the groups ofmembers highly interested in specific subjects, holds researchmeetings and/or seminars. Through these activities, JBA provided
support for promoting cooperation between bio-venture companies
or between bio-venture companies, forming human networks andsolving problems of bio-venture companies.

Research Meeting and Seminar

Preparation of statistical data on bio-venture business and directories
Statistical research on bio-venture business
JBA conducted questionnaire-based research on nationwide
bio-venture companies and carried out classification andstatistical analysis of bio-venture companies by prefecture andcategory. As a result, the number of bio-venture companies inJapan as of the end of 2009 was 558.
In addition, JBA conducted joint research with Hitotsubashi
University and published the results of analysis under the title“Initiation and growth of bio-venture companies” based on
JBAʼs “Statistical research on bio-venture companies (2008).”

Preparation of directories
Directories on the organization and latest information of
the bio-venture companies would be an important means
to share the information and promote open innovation.
JBA will continue to not only update the Metropolitan Bio
information but also prepare directories on nationwide
bio-venture companies effectively capitalizing on its own

10

Number of bio-venture companies
600
500
400
300
200
100
0

4

199

7

199

0

200

3

200

6

200

9 year200function as a base of activities. For the time being,
JBA is going to organize the drug discoveryrelated bio-venture information as soon aspracticable4

Activity Report 2011

actionInternational Network
JBA provides international information on biotechnology and bioindustry in cooperation
with member companies, universities and the government.

International activities of JBA include,( i ) Introduction/transmission of overseas bio-related information and events to themembers(ii ) Transmission of information on Japanese bioindustry.
(iii) Transmission of opinions on international issues as Japanese bio-organization.
(iv) Interaction with overseas bio-organizations through participation in international bio-events.
( v ) Making requests for participation in Bio Japan, and taking into consideration the wishes ofmember companies, JBA carries out the operations that seem hard for a single individual
or corporation to accomplish.

Member companies/academy
Venture member
Public members（METI, JETRO）
Domestic organizations（JPMA, STAFF）

Information service（Policies, investment
environment, researchand development activities）

Oﬀer/introduction of
the contact for inquiry
Support for publicity
Consulting

Acceptance of missions
Holding seminars
Alliance

Building a network
International cooperation

Overseas bio-organizations
Foreign companies, OECD
Foreign embassies in Japan

Accomplishment

International Comments
Statement of bioindustry organizations and the United
Nations on the Conference of the Parties to the
Framework Convention on Climate Change（COP15）
and the Kyoto Protocol（COP/MOP5）【Main points】“The negotiation document of the Special Working
Group（AWG-LCA）for long-term cooperation action
contains such descriptions that would bring about
obstacles to industrial development in that it regards
intellectual property as an obstacle to technology
transfer, proposing that the patent for climate-friendly
technology be void and proposing that the access tothe patent-pursuing technology be royalty-free and thatit recommends the exercise of compulsory licensing
against climate-friendly technology. JBA joined thestatement by the bio-industry organizations around theworld to the member states of the convention.

Support for Seminar Promoted
by Foreign embassies in Japan
French Embassy : Colloid Seminar Tokyo（2010.6）
Japan-French Seminor（2010.10）
British Embassy : UK Clinical Trial Seminar（2010.11）
HealthcareSeminar TOKYO（2011.2）
Mood Disorder Research : Science and Policy Seminar（2011.2）

Embassies and regional clusters with which JBA
cooperates.（20 countries, 36 organizations）[Overseas public organization]
American State Oﬃces Association, the State of Colorado,
the State of Georgia, the State of Massachusetts[Overseas embassy]
U.S.A, Canada, U.K., France. Switzerland, Netherlands,
Sweden, China, Hungary, etc.
[Regional cluster] Germany, Singapore, etc.
[Overseas bio-organization] U.S.A. (BIO), Europe(Europa-Bio), France, Germany, Sweden, Taiwan, etc.

11

4International Network

Creation of International Network
Written agreementwith overseas bio organizations■ BIO（U.S.）
Mutual cooperation in the U.S. BIO,
BioJapan and BioAsia.（since 2004）■ Swiss Biotech Association
Mutual cooperation（since 2005）■ Shanghai Biopharmaceutics Industries
Association
Mutual cooperation（since 2005）■ Russian Biotechnology Society
Mutual cooperation with no obligation（since 2009）■ CLIB2021（Bio-clusters of the Rhein region）/Cluster Bioindustllie Biotechnologi
Mutual cooperation with no obligation（since 2009）■ DECHEMA
Mutual cooperation with no obligation（since 2010）■ KoreaBIO
Mutual cooperation with no obligation（since 2010）

Cooperation in the OECD activities
The Working Party on Biotechnology（WPB）under theCommittee for Scientific and Technological Policy of
the OECD（Organization for Economic Cooperation
and Development）examines policy issues relating toresearch and development to industrialization throughlife science and biotechnology applied to a wide rangeof areas from medical care and pharmaceutical products
to the industries, environment, energy, agriculture and food.

JBA has participated in WPBʼs regular meetings andthe related conferences to support the Government,
and provides the status of discussions on wide-rangeof policy issues to its members. Recently, JBA helped
to disseminate its provisional translation “OECD
Guidelines on Human Biobanks and Genetic Research
Databases” which was adopted as an OECD council
recommendation（March 2010）.

Collection/provision of overseas bio information
Collection and provision of overseas
bio-information in cooperation withembassies, regional clusters, etc.
JBA has exchanged information withembassies, bio- organizations and regional
clusters of western and Asian countries.
JBA provides such information as overseas
policies,investment environment, industrial
trend and research and development
situation to its members through its journal“B&I” etc.

12Transmission of overseas policies andindustrial trend through the journal “B&I”

5

Activity Report 2011

actionEstablish the Infrastructure of Bioindustry
JBA is addressing the improvement of infrastructure for biotechnology and industrial development
in cooperation with member companies, universities and the government.

With regard to the enactment process and management of various laws andregulations on bioindustry in the fields of food and environment, JBA collects
and provides related information, and also holds explanatory meetings to collectand submit opinions from the industry.
In addition, JBA establishes various infrastructures for the development of
bioindustry such as support for human resource development in developing
countries through JICA, promotion of national research projects through the
management of research association, fosterage of promising young humanresources and awarding research prizes.

Corporate member
Venture member
AcademyInformation service
Countermeasure
Contact for inquiry
SupportVarious information on laws and regulations
Intellectual property, standardization, International
treaty, access to foreign genetic resources（CBD,
ABS, GMO, supplement, pharmaceutical）

Human resource
development
Encouraging research
activities

Researchcooperation

Research associationn of Molecular
Dynamics for Antibody Drug Development

Ⅰ Provision of informationon laws and regulations

Obtaininformation

Businesscooperation

Organization for Economic Cooperation
and Development（OECD）
Japan International Cooperation Agency（JICA）
Japan External Trade Organization（JETRO）

the Friends of Co-chairs on Liability and Redress (February 8 toFebruary 12, Malaysia)
Takashi Ishikawa, Ministry of Economy, Trade and Industry,
Manufacturing Industries Bureau, Bio-Industry Division, BioBusiness Promotion Oﬃce

JBA held an explanatory meeting on the utilization of
the type 2 (conﬁned use) of the Cartagena Law and aseminar on the negotiation on “Liability and Redress”
of Cartagena Protocol（March 8）“JBA held a seminar / hearing on “The current situationof the negotiation of the Cartagena Protocolʻ Liability
and Redress” and the impact of the remaining issues（points at issue）on industry” (July 27)

The latest trend in the regulations on experiments on living
modiﬁed organisms（LMO）
Toshiki Inoue, Ministry of Education, Culture, Sports, Scienceand Technology, Research Promotion Bureau, Life Science
Division, Office for Bioethics and Biosafety Ministry of
Education, Culture, Sports, Science and Technology
Cartagena Law : Matters to note for industrial use
Midori Kosugi, Ministry of Economy, Trade and Industry,
Manufacturing Industries Bureau, Bio-Industry Division, BioBusiness Promotion Oﬃce
Summary of the Cartagena Protocol “Meeting of the Group of

Prof. Akiho Shibata of Kobe University, who has been participatingin the above negotiations as a member of the Japanesedelegation since 2007, gave a lecture on the results of thenegotiations on “Liability and Redress” at the 3rd Meeting of theGroup of the Friends of Co-chairs and the remaining issues andtheir possible impact on bioindustry and the signiﬁcance thereof.
Furthermore, also in the presence of Mr. Masataka Okada, Head of
the Oﬃce of the Ministry of Economy, Trade and Industry who is amember of the delegation, an opportunity was arranged so that
concrete opinions from the industry might be given with regard
to products made by using LMO.

13

5

Establish the Infrastructureof Bioindustry

General Meeting of the Committee for Safe andthe Environment and special lecture meeting
JBA integrated opinions on the 5th Conference of the Parties to
the Cartagena Protocol（MOP5 : October 2010, Nagoya City）
One of the remaining points in dispute at present in terms of“Liability and Redress” is the Products Thereof made by using
LMO. The object of discussion of the Cartagena Protocol shouldhave originally been limited to LMO. “The Product Thereof”
should be excluded. In addition，it was confirmed that so
far as the use of LMO completely undermines the system
of science-based, advance safety / environmental impact

Ⅱ

Biological resources
measures/Cooperation fordeveloping countries

Support for international
negotiations of CBD and ABS

evaluation, the current discussion of “The Product Thereof”
should be demolished and that this fact should be conveyed as
the opinion of bioindustry to the government.
[Lecture] “International trend of nutrition / health claims
and the way food labeling should be in the future”
Hiroaki Hamano, Secretary-general, International Life
Sciences Institute (ILSI)With regard to nutrition/health claims, it is required that thefunctionality, effectiveness and safety should be evaluatedbased on the scientific evidence and fact and properly labeled.
The lecture was plainly made explaining the discussion trend of
highlighting as the global strategy of Japan, Asia, U.S., EU (EFSA)
and WHO and the importance etc. of the standardization of Codex.

Support for human resource
development in developing countries
JBA has been conducting JICA bioindustry group training since
FY 1988 to help nurture bio-related researchers, administrative
officers and others in developing countries. JBA has so far
brought in 200 trainees from 30 countries. Most of them areplaying an active role in the development of bioindustry intheir countries and also acting as a mediator with Japan.

JBA continuously has participated as a member of thegovernment delegation in international negotiation such as
the Conference of the Parties to the Convention on Biological
Diversity（CBD）and the meetings of working groups on accessand beneﬁt sharing（ABS）in order to support the government.

Help Desk for inquiry about ABS
JBA set up the Help Desk in April 2005 where the issues andproblems relating to access to foreign resources can be consulted.
Consultations are conducted in a confidential manner andthe number of consultations conducted as of the end of 2010
exceeded 300.

Preparation of “Guidelines on
Access to Genetic Resources”
Based on the CBD and the principles of Bonn Guidelines, JBA
published guidelines in March 2005 for Japanʼs overseas genetic
resource users. JBA has held open seminars in major cities
throughout Japan on a continuous basis to enhance publicawareness and understanding CBD-ABS.

Ⅲ

Intellectual property

In cooperating with bio-related organizations such as Japan
Pharmaceutical Manufacturers Association and Japan
Foods & Biotechnology Intellectual Property Rights Center,
JBA oﬀers its opinions to the Intellectual Property Strategy
Headquarters, Industrial Structure Council, Council for
Science and Technology Policy and Japan Patent Oﬃce.
In addition, under the co-sponsorship with Japan
Pharmaceutical Manufacturers Association, JBA organizes

14

Plant genetic engineering
Riken, Plant Science Center
Preparation anddiscussion of actionplans in their homecountry

Microbial isolation
Kitasato University

the “Life Science Intellectual Property Forum” every year
and hold a discussion on the issues of intellectual property
related to life science and bioindustry.
■ Integration of opinions on the formulation of the “Intellectual
Property Promotion Plan”（2010.1）■ Submitted its opinion about “What patent protection should
be in the ﬁeld of advanced medical technology”（2010.5）■ Cooperated in the survey of the Japan Patent Oﬃce as to thenecessity etc. to know the “Use Invention of Functional
Food” and recognize the novelty（2009.5）■ Survey of the “Patent application of the research results of
the university”（2010.6）

Activity Report 2011

Ⅳ

Human resource
development（fosterage ofpromising young human resources）

1

Special Sessions for bio leaders■ Course curriculum
Small-class lectures and exercises consisting of 30 lessons
given by top-rated corporate lecturers for the students
in the doctorʼs course of Tokyo Institute of Technology,
Graduate School of Bioscience and Biotechnology.

JBA is endeavoring to foster human resources thatwill contribute to the development of bioindustry, incooperation with member companies, universities and thegovernment.

2Inter-college Bio-Leaders■ Course curriculum
Two-night-three-day intensive course (up to 30 participants)
for nationwide postgraduates and young corporate
employees
Top lecture“Start-up business attaching importanceto people” Tomoyasu Toyoda
President, Ajinomoto Pharmaceuticals Co., Ltd.,

Discussion in groups
about the assigned
subjects

Lecture byTohoru Nishiyama“Necessity to improve the quality of the personnel for
doctors in the direction expected by the industry”

Ⅴ

Award and Grants

JBA promotes scientific research that contributes
to the growth and development of bioindustry byoﬀering award and grants.

JBA Award in 2010
“Es
“Establishment
E tablisht bof Cell Surface
Engineering and Its Development
to Biotechnology”
Mitsuyoshi, Ueda Professor
Division of Applied Life Sciences,
Kyoto University

The Grant for Researches on Chemical
and Biological Materials in 2010
“Na
“Nanobio-imaging
N nobiob iusing nanoparticle”
Shu, Taira Assistant Professor, Japan Advanced Institute of Scienceand Technology“Fluorescent labeling reagents for the visualization of intracellular
dynamics of endogenous growth factor receptors”
Shinya, Tsukiji Associate Professor,Nagaoka University of Technology“Application of Coenzyme B12-dependent Enzyme System toSynthesis of a Raw Material for Polytrimethylene Terephthalate”
Koichi, Mori Assistant Professor Okayama University

Fermentation and Metabolism
Research Grant in 2010
“Id
“Identiﬁ
dentiﬁcat
cation of mitochondrion as the breeding target ofyeast strains for alcoholic fermentation”
Hiroshi, Kitagaki Associate Professor, Saga University“Application of microbial enzymes in the production offunctional hydroxy amino acids”
Makoto, Hibi Assistant Professor, Kyoto University“Genetic indoctrination of Escherichia coli for innovative
drug discovery”
Kenji, Watanabe
Associate Professor
University of Shizuoka

15